Contrast Media Market Size, Share & Trends Analysis Report By Modality (Ultrasound, MRI), By Product (Microbubble, Gadolinium-based), By Application, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Contrast Media Market Size, Share & Trends Analysis Report By Modality (Ultrasound, MRI), By Product (Microbubble, Gadolinium-based), By Application, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2024 - 2030


Contrast Media Market Growth & Trends

The global contrast media market size is expected to reach USD 10.74 billion by 2030, registering a CAGR of 7.98% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases is fueling the demand for diagnostic imaging treatments, which is propelling the market forward. Imaging studies, such as MRI, have become an important aspect of most disease diagnoses, and the widespread use of imaging technologies in healthcare has boosted the demand for contrast media globally.

Chronic diseases like cancer and diabetes are quickly becoming a major public health concern and are among the leading causes of mortality worldwide, necessitating the development of early detection techniques and effective treatment alternatives. As a result, one of the key drivers of imaging tests and contrast agents is the rising prevalence of complicated comorbidities and long-term disorders, thus boosting the market worldwide.

Due to fewer patient visits to hospitals, the COVID-19 pandemic had a detrimental influence on the global contrast media market. The number of imaging cases in several radiology departments dropped dramatically. Many countries worldwide have begun to rebuild their economy, but it will take time for contrast media utilization rates to return to pre-pandemic levels. Furthermore, with the launch of COVID-19 vaccines and the relaxation of restrictions, raw material imports and exports have begun, indicating that the market will develop at a high rate throughout the projection period.

Contrast Media Market Report Highlights
  • On the basis of modality, the X-ray/Computed Tomography segment held the largest market share in 2023, accounting for 69.64%. Wide acceptance and cost-efficiency of the X-ray/CT modality boost the adoption of contrast agents used for this modality
  • Based on product type, the iodinated contrast media segment held the largest market share in 2023, accounting for 65.37%. This is due to their excellent radio-opacity and low toxicity than other agents
  • Based on application, the neurological disorders segment dominated the market and held the largest revenue share around 28.59% in 2023. Diagnostic evaluation of CNS for neurological disorders boosts the adoption of MRI contrast agents, as they provide better images of neural structures than CT
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Modality
1.1.2. Product
1.1.3. Application
1.1.4. Route of administration
1.1.5. End-use
1.1.6. Regional scope
1.1.7. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for Primary Interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for Primary Interviews in Latin America
1.3.5.5. Data for Primary Interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. Product outlook
2.2.3. Application outlook
2.2.4. Route of administration outlook
2.2.5. End-use outlook
2.2.6. Regional outlook
2.3. Competitive Insights
Chapter 3. Contrast Media Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Increasing prevalence of long-term diseases and complex comorbidities
3.4.1.2. Technological advancements
3.4.1.3. Label expansions
3.4.2. Market Restraint Analysis
3.4.2.1. Rising concern about MRI gadolinium agents retained in brain
3.5. Contrast Media Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Contrast Media Market: Modality Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Ultrasound
4.1.2. Magnetic Resonance Imaging
4.1.3. X-ray/Computed Tomography
4.2. Modality Market Share, 2023 & 2030
4.3. Segment Dashboard
4.4. Contrast Media Market by Modality Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Ultrasound
4.5.1.1. Ultrasound market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Magnetic Resonance Imaging
4.5.2.1. Magnetic resonance imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. X-ray/Computed Tomography
4.5.3.1. X-ray/computed tomography market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Contrast Media Market: Product Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Microbubble
5.1.2. Gadolinium-Based
5.1.3. Iodinated
5.1.4. Barium-Based
5.2. Product Market Share, 2023 & 2030
5.3. Segment Dashboard
5.4. Contrast Media Market by Product Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Microbubble
5.5.1.1. Microbubble market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Gadolinium-Based
5.5.2.1. Gadolinium-based Market Estimates and Forecast 2018 to 2030 (USD Million)
5.5.3. Iodinated
5.5.3.1. Iodinated market estimates and forecast 2018 to 2030 (USD Million)
5.5.4. Barium-Based
5.5.4.1. Barium-based Market Estimates and Forecast 2018 to 2030 (USD Million)
Chapter 6. Contrast Media Market: Application Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Cardiovascular Disorders
6.1.2. Neurological Disorders
6.1.3. Gastrointestinal Disorders
6.1.4. Cancer
6.1.5. Nephrological Disorders
6.1.6. Musculoskeletal Disorders
6.1.7. Others
6.2. Application Market Share, 2023 & 2030
6.3. Segment Dashboard
6.4. Contrast Media Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Cardiovascular Disorders
6.5.1.1. Cardiovascular disorders market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Neurological Disorders
6.5.2.1. Neurological disorders market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Gastrointestinal Disorders
6.5.3.1. Gastrointestinal disorders market estimates and forecast 2018 to 2030 (USD Million)
6.5.4. Cancer
6.5.4.1. Cancer market estimates and forecast 2018 to 2030 (USD Million)
6.5.5. Nephrological Disorders
6.5.5.1. Nephrological Disorders Market Estimates and forecast 2018 to 2030 (USD Million)
6.5.6. Musculoskeletal Disorders
6.5.6.1. Musculoskeletal disorders market estimates and forecast 2018 to 2030 (USD Million)
6.5.7. Others
6.5.7.1. Others market Estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Contrast Media Market: Route Of Administration Estimates & Trend Analysis
7.1. Definitions and Scope
7.1.1. Intravenous
7.1.2. Oral Route
7.1.3. Rectal Route
7.2. Route of Administration Market Share, 2023 & 2030
7.3. Segment Dashboard
7.4. Contrast Media Market by Route of Administration Outlook
7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5.1. Intravenous
7.5.1.1. Intravenous market Estimates and forecast 2018 to 2030 (USD Million)
7.5.2. Oral Route
7.5.2.1. Oral route market estimates and forecast 2018 to 2030 (USD Million)
7.5.3. Rectal Route
7.5.3.1. Rectal route market estimates and forecast 2018 to 2030 (USD Million)
Chapter 8. Contrast Media Market: End-use Estimates & Trend Analysis
8.1. Definitions and Scope
8.1.1. Hospitals
8.1.2. Diagnostic Imaging Centers
8.1.3. Others
8.2. End-use Market Share, 2023 & 2030
8.3. Segment Dashboard
8.4. Contrast Media Market by End-use Outlook
8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5.1. Hospitals
8.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
8.5.2. Diagnostic Imaging Centers
8.5.2.1. Diagnostic imaging centers market estimates and forecast 2018 to 2030 (USD Million)
8.5.3. Others
8.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 9. Contrast Media Market: Regional Estimates & Trend Analysis
9.1. Regional market share analysis, 2023 & 2030
9.2. Regional Market Dashboard
9.3. Global Regional Market Snapshot
9.4. Regional Market Share and Leading Players, 2023
9.4.1. North America
9.4.2. Europe
9.4.3. Asia Pacific
9.4.4. Latin America
9.4.5. Middle East and Africa
9.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
9.6. North America
9.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
9.6.2. U.S.
9.6.2.1. Key country dynamics
9.6.2.2. Competitive scenario
9.6.2.3. Regulatory framework
9.6.2.4. Reimbursement scenario
9.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
9.6.3. Canada
9.6.3.1. Key country dynamics
9.6.3.2. Competitive scenario
9.6.3.3. Regulatory framework
9.6.3.4. Reimbursement scenario
9.6.3.5. Canada market estimates and forecasts, 2018 - 2030
9.7. Europe
9.7.1. UK
9.7.1.1. Key country dynamics
9.7.1.2. Competitive scenario
9.7.1.3. Regulatory framework
9.7.1.4. Reimbursement scenario
9.7.1.5. UK market estimates and forecasts, 2018 - 2030
9.7.2. Germany
9.7.2.1. Key country dynamics
9.7.2.2. Competitive scenario
9.7.2.3. Regulatory framework
9.7.2.4. Reimbursement scenario
9.7.2.5. Germany market estimates and forecasts, 2018 - 2030
9.7.3. France
9.7.3.1. Key country dynamics
9.7.3.2. Competitive scenario
9.7.3.3. Regulatory framework
9.7.3.4. Reimbursement scenario
9.7.3.5. France market estimates and forecasts, 2018 - 2030
9.7.4. Italy
9.7.4.1. Key country dynamics
9.7.4.2. Competitive scenario
9.7.4.3. Regulatory framework
9.7.4.4. Reimbursement scenario
9.7.4.5. Italy market estimates and forecasts, 2018 - 2030
9.7.5. Spain
9.7.5.1. Key country dynamics
9.7.5.2. Competitive scenario
9.7.5.3. Regulatory framework
9.7.5.4. Reimbursement scenario
9.7.5.5. Spain market estimates and forecasts, 2018 - 2030
9.7.6. Denmark
9.7.6.1. Key country dynamics
9.7.6.2. Competitive scenario
9.7.6.3. Regulatory framework
9.7.6.4. Reimbursement scenario
9.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
9.7.7. Sweden
9.7.7.1. Key country dynamics
9.7.7.2. Competitive scenario
9.7.7.3. Regulatory framework
9.7.7.4. Reimbursement scenario
9.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
9.7.8. Norway
9.7.8.1. Key country dynamics
9.7.8.2. Competitive scenario
9.7.8.3. Regulatory framework
9.7.8.4. Reimbursement scenario
9.7.8.5. Norway market estimates and forecasts, 2018 - 2030
9.8. Asia Pacific
9.8.1. Japan
9.8.1.1. Key country dynamics
9.8.1.2. Competitive scenario
9.8.1.3. Regulatory framework
9.8.1.4. Reimbursement scenario
9.8.1.5. Japan market estimates and forecasts, 2018 - 2030
9.8.2. India
9.8.2.1. Key country dynamics
9.8.2.2. Competitive scenario
9.8.2.3. Regulatory framework
9.8.2.4. Reimbursement scenario
9.8.2.5. India market estimates and forecasts, 2018 - 2030
9.8.3. China
9.8.3.1. Key country dynamics
9.8.3.2. Competitive scenario
9.8.3.3. Regulatory framework
9.8.3.4. Reimbursement scenario
9.8.3.5. China market estimates and forecasts, 2018 - 2030
9.8.4. South Korea
9.8.4.1. Key country dynamics
9.8.4.2. Competitive scenario
9.8.4.3. Regulatory framework
9.8.4.4. Reimbursement scenario
9.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
9.8.5. Australia
9.8.5.1. Key country dynamics
9.8.5.2. Competitive scenario
9.8.5.3. Regulatory framework
9.8.5.4. Reimbursement scenario
9.8.5.5. Australia market estimates and forecasts, 2018 - 2030
9.8.6. Thailand
9.8.6.1. Key country dynamics
9.8.6.2. Competitive scenario
9.8.6.3. Regulatory framework
9.8.6.4. Reimbursement scenario
9.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
9.9. Latin America
9.9.1. Brazil
9.9.1.1. Key country dynamics
9.9.1.2. Competitive scenario
9.9.1.3. Regulatory framework
9.9.1.4. Reimbursement scenario
9.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
9.9.2. Mexico
9.9.2.1. Key country dynamics
9.9.2.2. Competitive scenario
9.9.2.3. Regulatory framework
9.9.2.4. Reimbursement scenario
9.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
9.9.3. Argentina
9.9.3.1. Key country dynamics
9.9.3.2. Competitive scenario
9.9.3.3. Regulatory framework
9.9.3.4. Reimbursement scenario
9.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
9.10. MEA
9.10.1. South Africa
9.10.1.1. Key country dynamics
9.10.1.2. Competitive scenario
9.10.1.3. Regulatory framework
9.10.1.4. Reimbursement scenario
9.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
9.10.2. Saudi Arabia
9.10.2.1. Key country dynamics
9.10.2.2. Competitive scenario
9.10.2.3. Regulatory framework
9.10.2.4. Reimbursement scenario
9.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
9.10.3. UAE
9.10.3.1. Key country dynamics
9.10.3.2. Competitive scenario
9.10.3.3. Regulatory framework
9.10.3.4. Reimbursement scenario
9.10.3.5. UAE market estimates and forecasts, 2018 - 2030
9.10.4. Kuwait
9.10.4.1. Key country dynamics
9.10.4.2. Competitive scenario
9.10.4.3. Regulatory framework
9.10.4.4. Reimbursement scenario
9.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.2.1. Innovators
10.3. Vendor Landscape
10.3.1. List of key distributors and channel partners
10.3.2. Key customers
10.3.3. Key company market share analysis, 2023
10.3.4. Bayer AG
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Product benchmarking
10.3.4.4. Strategic initiatives
10.3.5. General Electric Company
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Product benchmarking
10.3.5.4. Strategic initiatives
10.3.6. Guerbet
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Product benchmarking
10.3.6.4. Strategic initiatives
10.3.7. Bracco Diagnostic, Inc.
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Product benchmarking
10.3.7.4. Strategic initiatives
10.3.8. Nano Therapeutics Pvt. Ltd.
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Product benchmarking
10.3.8.4. Strategic initiatives
10.3.9. Lantheus Medical Imaging, Inc.
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Product benchmarking
10.3.9.4. Strategic initiatives
10.3.10. iMAX
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Product benchmarking
10.3.10.4. Strategic initiatives
10.3.11. Trivitron Healthcare
10.3.11.1. Company overview
10.3.11.2. Financial performance
10.3.11.3. Product benchmarking
10.3.11.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings